Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...
BOSTON, June 18, 2024 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, has launched a ...
Zacks Investment Research on MSN
Haemonetics (HAE) is a top-ranked value stock: Should you buy?
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...
In the latest quarter, 5 analysts provided ratings for Haemonetics (NYSE:HAE), showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...
Haemonetics (NYSE:HAE) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below provides a concise overview of ...
Haemonetics Corporation (NYSE: HAE) on Friday said it will acquire Ireland-based Vivasure Medical Limited, a move aimed at strengthening its position in structural heart and endovascular procedures, ...
BOSTON, Oct. 9, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2026 financial results at 6:00 am ET on Thursday, ...
BOSTON, Jan. 2, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference in San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results